Description
Resistance of Cancer Cells to CTL-Mediated Immunotherapy, 2015
Resistance to Targeted Anti-Cancer Therapeutics Series, Vol. 7
Language: EnglishSubject for Resistance of Cancer Cells to CTL-Mediated Immunotherapy:
Publication date: 10-2016
Support: Print on demand
Publication date: 06-2015
353 p. · 15.5x23.5 cm · Hardback
Description
/li>Contents
/li>Biography
/li>Comment
/li>
Benjamin Bonavida, Ph.D., is Professor, UCLA David Geffen School of Medicine for the Department of Microbiology, Immunology & Molecular Genetics. He is also Member, Department of Defense Congressionally Directed Medical Research Program, Member, National Cancer Institute SPORE Program, Member, International Scientific Advisory Board of the Israel Cancer Research Foundation, among other accomplishments. He is currently a scientific reviewer for several journals and a member of editorial boards including Journal of Clinical Immunology, International Journal of Oncology, and Cancer Biotherapy & Radiopharmaceuticals. He has published over 450 papers and reviews, has received more than 7,980 citations, and has edited four Springer volumes.
Salem Chouaib, Ph.D., is Head, Cancer Immunology Division at Institut Gustave Roussy. His research focuses on augmenting cytotoxic T cell immunity and studies how tumors evade the immune system. Dr. Chouaib has published more than 239 scientific papers and reviews, and has received more than 5,490 citations.